ATE194167T1 - Ein prozess für die herstellung von faktor ix biologischen ursprungs - Google Patents

Ein prozess für die herstellung von faktor ix biologischen ursprungs

Info

Publication number
ATE194167T1
ATE194167T1 AT96904778T AT96904778T ATE194167T1 AT E194167 T1 ATE194167 T1 AT E194167T1 AT 96904778 T AT96904778 T AT 96904778T AT 96904778 T AT96904778 T AT 96904778T AT E194167 T1 ATE194167 T1 AT E194167T1
Authority
AT
Austria
Prior art keywords
pct
factor
production
biological origin
sec
Prior art date
Application number
AT96904778T
Other languages
English (en)
Inventor
Djuro Josic
Lutz Hoffer
Frank Morfeld
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Application granted granted Critical
Publication of ATE194167T1 publication Critical patent/ATE194167T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT96904778T 1995-02-25 1996-02-14 Ein prozess für die herstellung von faktor ix biologischen ursprungs ATE194167T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19506633A DE19506633A1 (de) 1995-02-25 1995-02-25 Verfahren zur Herstellung von Faktor IX aus biologischen Quellen
PCT/EP1996/000636 WO1996027003A1 (en) 1995-02-25 1996-02-14 A process for the preparation of factor ix from biological sources

Publications (1)

Publication Number Publication Date
ATE194167T1 true ATE194167T1 (de) 2000-07-15

Family

ID=7755037

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96904778T ATE194167T1 (de) 1995-02-25 1996-02-14 Ein prozess für die herstellung von faktor ix biologischen ursprungs

Country Status (20)

Country Link
US (1) US5919909A (de)
EP (1) EP0811058B1 (de)
JP (1) JPH11500910A (de)
KR (1) KR100436857B1 (de)
CN (1) CN1105779C (de)
AT (1) ATE194167T1 (de)
AU (1) AU697217B2 (de)
CA (1) CA2213577C (de)
DE (2) DE19506633A1 (de)
DK (1) DK0811058T3 (de)
EA (1) EA000222B1 (de)
ES (1) ES2147365T3 (de)
FI (1) FI119377B (de)
GR (1) GR3034035T3 (de)
IL (1) IL117157A (de)
MY (1) MY119366A (de)
PT (1) PT811058E (de)
UA (1) UA46005C2 (de)
WO (1) WO1996027003A1 (de)
ZA (1) ZA961450B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19506633A1 (de) * 1995-02-25 1996-08-29 Octapharma Ag Verfahren zur Herstellung von Faktor IX aus biologischen Quellen
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
WO2005033140A1 (ja) * 2003-09-30 2005-04-14 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 高純度血液凝固ｉｘ因子調製物およびその精製方法
KR100567448B1 (ko) * 2003-11-05 2006-04-04 주식회사 인투젠 형질전환 동물의 유즙 전처리방법 및 이를 통한 인체단백질의 정제방법
DE602005024955D1 (de) 2004-03-19 2011-01-05 Baxter Healthcare Sa Faktor ixa zur behandlung von blutungsstörungen
US10928366B2 (en) * 2007-01-26 2021-02-23 Sigma-Aldrich Co. Llc Compositions and methods for combining protein precipitation and solid phase extraction
US10434492B2 (en) * 2007-01-26 2019-10-08 Sigma-Aldrich Co. Llc Compositions and methods for solid phase extraction of lipids
TR201911082T4 (tr) * 2010-03-30 2019-08-21 Octapharma Ag K vitaminine bağımlı proteinlerin saflaştırılması için bir işlem.
CN104560925B (zh) * 2014-12-30 2017-11-03 山东泰邦生物制品有限公司 一种从人凝血因子ⅸ层析废液中激活制备人凝血酶的方法
CN107540743A (zh) * 2017-10-11 2018-01-05 南岳生物制药有限公司 一种双层析法制备人纤维蛋白原的方法
CN111378029B (zh) * 2018-12-29 2023-05-05 四川远大蜀阳药业有限责任公司 一种人凝血因子ix的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3473407D1 (en) * 1983-05-02 1988-09-22 Immuno Ag Method of inactivating pathogens
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
DE3877529T2 (de) * 1987-10-23 1996-11-07 Centre Regional De Transfusion Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat und dessen therapeutische Verwendung.
AT402261B (de) * 1991-01-25 1997-03-25 Immuno Ag Komplex enthaltend den gerinnungsfaktor ix
BR9205700A (pt) * 1991-03-01 1994-06-28 Rhone Poulenc Rorer Int Aperfeiçoamento em um processo para purificar e preservar fator IX derivado de plasma do sangue humano ou outra fonte, processos para a preparação de uma composição terapêutica, e para estabilizar fator IX, solução aquosa de fator IX parcialmente purificado, composição terapêutica e processo para tratar doença de christmas.
ATE168274T1 (de) 1993-02-09 1998-08-15 Octapharma Ag Verfahren zur inaktivierung von viren, die nicht mit lipidhüllen versehen sind
DE19506633A1 (de) * 1995-02-25 1996-08-29 Octapharma Ag Verfahren zur Herstellung von Faktor IX aus biologischen Quellen

Also Published As

Publication number Publication date
AU697217B2 (en) 1998-10-01
GR3034035T3 (en) 2000-11-30
MY119366A (en) 2005-05-31
EP0811058A1 (de) 1997-12-10
AU4876196A (en) 1996-09-18
CN1105779C (zh) 2003-04-16
FI119377B (fi) 2008-10-31
IL117157A (en) 1999-12-22
CA2213577C (en) 2005-01-04
DE69609054D1 (de) 2000-08-03
PT811058E (pt) 2000-10-31
DE19506633A1 (de) 1996-08-29
EA000222B1 (ru) 1998-12-24
EP0811058B1 (de) 2000-06-28
KR19980702453A (ko) 1998-07-15
DE69609054T2 (de) 2001-03-08
CN1181782A (zh) 1998-05-13
ZA961450B (en) 1996-08-27
FI973469A (fi) 1997-08-22
EA199700196A1 (ru) 1998-02-26
UA46005C2 (uk) 2002-05-15
US5919909A (en) 1999-07-06
WO1996027003A1 (en) 1996-09-06
JPH11500910A (ja) 1999-01-26
FI973469A0 (fi) 1997-08-22
ES2147365T3 (es) 2000-09-01
DK0811058T3 (da) 2000-10-16
KR100436857B1 (ko) 2004-09-21
CA2213577A1 (en) 1996-09-06
IL117157A0 (en) 1996-06-18

Similar Documents

Publication Publication Date Title
DE60230274D1 (de) Verfahren zur herstellung von l-aminosäuren durch enterobacteriaceae-stämmen mit verstärkter expression des pts-g
DE19681532T1 (de) Verfahren zur Herstellung von L-Glutaminsäure durch Fermentation
ATE194167T1 (de) Ein prozess für die herstellung von faktor ix biologischen ursprungs
DE69007800D1 (de) Verfahren zur fermentativen Herstellung von L-Arginin.
DE59609824D1 (de) Verfahren zur herstellung von substituierten arylmilchsäure-haltigen cyclodepsipeptiden mit 24 ringatomen
DE69629299D1 (de) Prozess für die produktion von l-lysin durch fermentation
DE69823662D1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
DE69808086D1 (de) Ein verfahren zur herstellung von 1,4,7,10-tetraazacyclododecan-1,4,7-triessigsäure und deren derivaten
ATE101144T1 (de) Verfahren zur herstellung von cyclischen sulfaten.
DE69519799D1 (de) Verfahren zur herstellung von [s,s]-ethylendiamin-n,n'-dibernsteinsäure
DE69010256D1 (de) Verfahren zur Herstellung von L-Ornithin durch Fermentation.
ATE101846T1 (de) Verfahren zur herstellung von 1,1dichlorotetrafluorethan.
DE69009394D1 (de) Verfahren zur Herstellung von 3-Cyano-3,5,5-trimethyl-1-cyclohexanon.
ATE235461T1 (de) Verfahren zur herstellung von 3-cyano-2,4- dihalogen-5-fluor-benzoesäuren
DE69513408D1 (de) Ein verbessertes verfahren für die herstellung von seitenketten-derivaten von cyclohexapeptidyl-lipopeptiden
DE59603295D1 (de) Verfahren zur herstellung von dolastatin 15 und deren zwischenprodukten
DE59803194D1 (de) Verfahren zur herstellung von 1,3-disubstituierten 2-nitroguanidinen
DE59008482D1 (de) Verfahren zur Herstellung von 2,4,5-Triamino-6-hydroxypyrimidin durch katalytische Hydrierung von 2,4-Diamino-6-hydroxy-5-nitrosopyrimidin.
ATE81013T1 (de) Verfahren zur herstellung von faktor viii:cmangelplasma und ein so erhaltenes mangelplasma.
DE59007022D1 (de) Verfahren zur kontinuierlichen Herstellung von Nylon 4,6.
DE59809481D1 (de) Verfahren zur Herstellung von Aminocyanacetamid
DE69802171T8 (de) Verfahren zur Herstellung von 5,6-Dihydro-11H-dibenzo[a,d]cyclohept-11-enen
DE59605866D1 (de) Verfahren zur Herstellung von 2,2-Dialkylaryliden-cycloalkanonen
ATE221550T1 (de) Beschleuniger für die herstellung von polyamiden aus aminonitrilen
DE59603908D1 (de) Verfahren zur Herstellung von N',N'-disubstituierten 1,4-Diaminoanthrachinonen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification